Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2022-10-25
2023-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Digital Noise Reduction Strategies: A Hearing Aid Trial
NCT00261768
fNIRS, Listening Effort, and Motivation
NCT05893992
Societal Merit of Intervention on Hearing Loss Evaluation
NCT05525221
fNIRs, Listening Effort, and Speech Intelligibility
NCT05330585
Predicting Success With Hearing Aids
NCT00371449
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The Food and Drug Administration (FDA) issued a proposal in 2021 to make hearing care more accessible for Americans, known as the Over-the-Counter Hearing Aid Act, part of the FDA Reauthorization Act of 2017. Unlike conventional hearing aids, these devices will not require appointments to an audiologist for adjustments. Due to their affordability and easy access, DTC hearing aids have the potential to reach more individuals with hearing loss. Despite the many potential benefits that DTC hearing aids could offer, there is little research into their use to meet unique patient listening needs and the accuracy of self-guided hearing aid fittings.
The investigators will evaluate the benefit of DTC hearing aids via questionnaires and a conversation task the participant engages in with a familiar speaker.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DTC Hearing Aid
DTC Hearing Aids
DTC hearing aid programmed to the individual participant.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DTC Hearing Aids
DTC hearing aid programmed to the individual participant.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. No vision impairment that would interfere with the ability to complete study tasks (i.e., legally blind, severe cataracts, or macular degeneration)
3. Bilateral mild to moderate sensorineural or mixed hearing loss
4. Pass a cognitive screener
5. Minimum Grade 10 education
6. Ability to attend all study visits
7. Eligible communication partner who can attend first study visit.
Exclusion Criteria
2. History of unresolved communication difficulties following another neurological problem (i.e., stroke or brain tumor), neurodevelopmental disorder (i.e., Down's syndrome), or head/neck cancer
3. Diagnosis of dementia or cognitive impairment
4. Positive history of major psychiatric disorder (i.e., schizophrenia, significant untreated depression)
5. Co-enrolled in other intervention studies targeting hearing, language, or communication strategies
6. History or current fluctuating hearing loss
7. Evidence of conductive hearing loss
8. Current active hearing aid wearer (defined as wearing hearing aid(s) at least 4 hours a day for most days within the past year)
9. Current active hearing aid wearer within 30-day trial period of purchased hearing aids from a licensed provider
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Northwestern University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pamela Souza
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pamela Souza, PhD
Role: PRINCIPAL_INVESTIGATOR
Northwestern University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Northwestern University
Chicago, Illinois, United States
Northwestern University
Evanston, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STU00217791
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.